Browse 142 market data tables and 39 figures spread through 177 pages and in-depth TOC on “Sleep Apnea Devices Market”
http://www.marketsandmarkets.com/Market-Reports/sleep-apnea-devices-market-719.html
Early buyers will receive 10% customization on this report.

Prominent Players:

The prominent players in the global sleep apnea devices market include ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand). These companies are dominant in the market mainly due to their well-established presence in the field of sleep apnea devices, presence in over 50 countries, high R&D investments, and strong sales and distribution force.

Other players include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Weinmann Medical Devices GmbH (Germany), Whole You, Inc. (U.S.), BMC Medical Co., Ltd. (China) and DeVilbiss Healthcare (U.S.), and Braebon Medical Corporation (Canada).

Download The PDF Brochure@
http://www.marketsandmarkets.com/pdfdownload.asp?id=719

Geographical Analysis:

In 2016, North America is estimated to account for the largest share in the forecast period of the market, followed by Europe and Asia-Pacific. The European regional segment is projected to register the highest CAGR during the forecast period.

This can be attributed to the new legislation of PAP devices, growing funding and grants for sleep apnea devices and treatment, introduction of new devices in the European market, and focus of industry players.

Read More | Get the Sample Pages@
http://www.marketsandmarkets.com/requestsample.asp?id=719

Market Dynamics:

Factors such as growing awareness regarding the ill effects of sleep apnea, growing usage of oral appliances for sleep apnea treatment, and the large pool of undiagnosed and untreated sleep apnea patients are driving the growth of the market. Additionally, technological advancements in sleep apnea devices is also supporting the growth of the market.

On the other hand, lack of patient compliance and alternative treatments for sleep apnea are factors restricting market growth to a certain extent. Emerging markets in developing countries and increasing venture capital (VC) funding are expected to provide immense opportunities for players in the market.

About MarketsandMarkets:
MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. For more information, please visit www.marketsandmarkets.com

Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No : 1-888-600-6441